Methods of treating or preventing cholesterol related disorders

Disclosed and claimed is a method of lowering serum LDL cholesterol in a patient comprising administering at least one anti-PCSK9 antibody to the patient in need thereof at a dose of about 105-280mg wherein said dose is to be administered at a frequency of from once per week to once every four weeks...

Full description

Saved in:
Bibliographic Details
Main Authors Gibbs, John P, Wasserman, Scott, Scott, Robert Andrew Donald, Chan, Joyce Chi Yee, Stein, Evan, Clogston, Christi L, Osslund, Timothy David, Dias, Clapton S
Format Patent
LanguageEnglish
Published 27.08.2021
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Disclosed and claimed is a method of lowering serum LDL cholesterol in a patient comprising administering at least one anti-PCSK9 antibody to the patient in need thereof at a dose of about 105-280mg wherein said dose is to be administered at a frequency of from once per week to once every four weeks, and wherein said medicament is capable of lowering said serum LDL cholesterol level by at least about 15%. Wherein PCSK9 comprises the amino acids of SEQ ID NO 1 and the antibody is defined by 90% identity to SEQ Id NO: 23 and 49 or by the CDRs therein.
AbstractList Disclosed and claimed is a method of lowering serum LDL cholesterol in a patient comprising administering at least one anti-PCSK9 antibody to the patient in need thereof at a dose of about 105-280mg wherein said dose is to be administered at a frequency of from once per week to once every four weeks, and wherein said medicament is capable of lowering said serum LDL cholesterol level by at least about 15%. Wherein PCSK9 comprises the amino acids of SEQ ID NO 1 and the antibody is defined by 90% identity to SEQ Id NO: 23 and 49 or by the CDRs therein.
Author Scott, Robert Andrew Donald
Stein, Evan
Gibbs, John P
Dias, Clapton S
Wasserman, Scott
Chan, Joyce Chi Yee
Osslund, Timothy David
Clogston, Christi L
Author_xml – fullname: Gibbs, John P
– fullname: Wasserman, Scott
– fullname: Scott, Robert Andrew Donald
– fullname: Chan, Joyce Chi Yee
– fullname: Stein, Evan
– fullname: Clogston, Christi L
– fullname: Osslund, Timothy David
– fullname: Dias, Clapton S
BookMark eNrjYmDJy89L5WSw900tychPKVbIT1MoKUpNLMnMS1fIL1IoKEotS80D85Iz8nNSi0tSi_JzFIpScxJLUlMUUjKL84tSUouKeRhY0xJzilN5oTQ3g5yba4izh25qQX58anFBYnJqXmpJvF-UuaG5qamBozFBBQC-ZzI8
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID NZ717550A
GroupedDBID EVB
ID FETCH-epo_espacenet_NZ717550A3
IEDL.DBID EVB
IngestDate Fri Sep 20 10:08:41 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_NZ717550A3
Notes Application Number: NZ20120717550
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210827&DB=EPODOC&CC=NZ&NR=717550A
ParticipantIDs epo_espacenet_NZ717550A
PublicationCentury 2000
PublicationDate 20210827
PublicationDateYYYYMMDD 2021-08-27
PublicationDate_xml – month: 08
  year: 2021
  text: 20210827
  day: 27
PublicationDecade 2020
PublicationYear 2021
RelatedCompanies AMGEN INC
RelatedCompanies_xml – name: AMGEN INC
Score 3.3472123
Snippet Disclosed and claimed is a method of lowering serum LDL cholesterol in a patient comprising administering at least one anti-PCSK9 antibody to the patient in...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Methods of treating or preventing cholesterol related disorders
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20210827&DB=EPODOC&locale=&CC=NZ&NR=717550A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LS8NAEB5qFfWm9f0oe5Dcgk1389hDKDYPipC0SJXSS8ljK4IkoYn4951dUvXS2z5gmR2Ynfl2Z74FeODUoowKW7cS4egsybme8CF2TW6kqc0GuaJSimJr8sqeF-aiA-_bWhjFE_qtyBHRojK090ad19XfJZavcivrx_QDh8pROHd9rUXHiF-coa35YzeYTf2pp3meGy-1-MVF1IKx-NMe7MsYWpLsB29jWZJS_fcn4QkczHCpojmFjih6cORtv13rwWHUvnZjszW8-gxGkfrpuSblmqjccPQ4pNyQqmVgwp48xxTtQflJVIWKyEnecmvW59APg7k30VGS1e-eV_GylZheQLcoC3EFxGAmAtncyQRPGM0MB0NOPuBUCGak9jq5hssdi9zsnLmFY6k2eUs6tO-g22y-xD262SbtKxX9AAnyg5E
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1LT4NAEJ7Uaqw3re9H3YPhRizsUtgDaSyUVC20MdU0vRAoW2NigBSMf99hQ9VLb_tINrOTzM58uzPfAtxx2qOMClPtRcJSWZRwNeI6dg2uxbHJuomkUvKD3uiVPc2NeQPeN7Uwkif0W5IjokUt0d5LeV7nf5dYrsytLO7jDxzK-t7MdpUaHSN-sXRTcQf2cDpxJ47iOHawUIIXG1ELxuIPO7BrVtS8Vdz0NqhKUvL__sQ7hL0pLpWWR9AQaRtazubbtTbs-_VrNzZrwyuOoe_Ln54Lkq2IzA1Hj0OyNclrBibsVeeYpD3IPomsUBEJSWpuzeIEOt5w5oxUlCT83XMYLGqJ6Sk00ywV50A0ZiCQTayl4BGjS83CkJN3ORWCabG5ii7gbMsil1tnbqE1mvnjcPwYPF_BQaXC6sZUN6-hWa6_xA263DLuSHX9AFlOhn4
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Methods+of+treating+or+preventing+cholesterol+related+disorders&rft.inventor=Gibbs%2C+John+P&rft.inventor=Wasserman%2C+Scott&rft.inventor=Scott%2C+Robert+Andrew+Donald&rft.inventor=Chan%2C+Joyce+Chi+Yee&rft.inventor=Stein%2C+Evan&rft.inventor=Clogston%2C+Christi+L&rft.inventor=Osslund%2C+Timothy+David&rft.inventor=Dias%2C+Clapton+S&rft.date=2021-08-27&rft.externalDBID=A&rft.externalDocID=NZ717550A